Evidence map›Paper›PMID 36614944›Full record

ArticleJournal of clinical medicine2022

Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 Infection.

Leszek Gromadziński, Maciej Żechowicz, Beata Moczulska, Michał Kasprzak, Klaudyna Grzelakowska, Paulina Nowek, Dominika Stępniak, Natalia Jaje-Rykowska, Aleksandra Kłosińska, Mikołaj Pożarowszczyk and 12 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Leszek GromadzińskiDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.ORCID 0000-0002-8827-4203
Maciej ŻechowiczDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.ORCID 0000-0003-2841-0565
Beata MoczulskaDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Michał KasprzakCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Klaudyna GrzelakowskaCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Paulina NowekDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Dominika StępniakDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Natalia Jaje-RykowskaDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Aleksandra KłosińskaSchool of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Mikołaj PożarowszczykSchool of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.ORCID 0000-0002-9214-5295
Aleksandra WochnaSchool of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Adam KernDepartment of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.
Jerzy RomaszkoDepartment of Family Medicine and Infectious Diseases, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland.ORCID 0000-0002-7929-6822
Agata SobackaCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Przemysław PodhajskiCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Aldona KubicaCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Jacek KryśCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Maciej PiaseckiCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Piotr LackowskiCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Małgorzata JasiewiczCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Eliano Pio NavareseCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Jacek KubicaCollegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.
Nicolaus Copernicus University · PLUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The identification of parameters that would serve as predictors of prognosis in COVID-19 patients is very important. In this study, we assessed independent factors of in-hospital mortality of COVID-19 patients during the second wave of the pandemic. Material and methods: The study group consisted of patients admitted to two hospitals and diagnosed with COVID-19 between October 2020 and May 2021. Clinical and demographic features, the presence of comorbidities, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parameters with in-hospital mortality was evaluated. Results: A total of 1040 COVID-19 patients (553 men and 487 women) qualified for the study. The in-hospital mortality rate was 26% across all patients. In multiple logistic regression analysis, age ≥ 70 years with OR = 7.8 (95% CI 3.17−19.32), p < 0.001, saturation at admission without oxygen ≤ 87% with OR = 3.6 (95% CI 1.49−8.64), p = 0.004, the presence of typical COVID-19-related lung abnormalities visualized in chest computed tomography ≥40% with OR = 2.5 (95% CI 1.05−6.23), p = 0.037, and a concomitant diagnosis of coronary artery disease with OR = 3.5 (95% CI 1.38−9.10), p = 0.009 were evaluated as independent risk factors for in-hospital mortality. Conclusion: The relationship between clinical and laboratory markers, as well as the advancement of lung involvement by typical COVID-19-related abnormalities in computed tomography of the chest, and mortality is very important for the prognosis of these patients and the determination of treatment strategies during the COVID-19 pandemic.

Indexed as

COVID-19mortalityprognosisrisk factorsSARS-CoV-2 infection

Identifiers

PMID36614944
PMCPMC9821385
OpenAlexW4313260929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.